Fischer Medical Ventures Share Price
36.31-0.72 (-1.94%)
-66.23% past 1 Year
Fischer Chemic Ltd is a certified supplier of APIs&intermediate Herbal Medicine Food Additives Cosmetics Raw Materials Laboratory Instrument&Chemicals PVC Modifier Aquaculture equipments etc. They have two manufacturing bases located in
Corporate filings & documents
Announcements
Intimation of Record Date for E-Voting and payment of Dividend to Shareholders
21 hours agoIntimation of Record Date for E-Voting and payment of Dividend to Shareholders
21 hours agoI)Approval of Appointment of Independed DirectorII)Approval of AGM Notice & Book ClosureIII) Reconstitution of Committee
22 hours agoI)Approval of Appointment of Independed DirectorII)Approval of AGM Notice & Book ClosureIII) Reconstitution of Committee
22 hours agoFischer Medical Ventures Ltd informed the exchange on the Press Release titled Time Medical International Ventures launches Next-generation CLARION 64/128- Slice AI-driven CT system at India Health Expo 2026
6 days agoFischer Medical Ventures Ltd informed the exchange on the Press Release titled Time Medical International Ventures launches Next-generation CLARION 64/128- Slice AI-driven CT system at India Health Expo 2026
6 days agoFischer Medical Ventures Limited has informed the exchange on the press release titled "Catanduanes Integrated Digital Healthcare project Awarded to Time Medical Philippines".
1 week agoFischer Medical Ventures Limited has informed the exchange on the press release titled "Catanduanes Integrated Digital Healthcare project Awarded to Time Medical Philippines".
1 week agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Shankar Varadharajan & Others
2 weeks agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Shankar Varadharajan & Others
2 weeks agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Shankar Varadharajan & PACs
2 weeks agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Shankar Varadharajan & PACs
2 weeks agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Shankar Varadharajan & Others
2 weeks agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Shankar Varadharajan & Others
2 weeks agoAllotment of equity shares pursuant to conversion of warrants
2 weeks agoAllotment of equity shares pursuant to conversion of warrants
2 weeks agoAllotment of equity shares pursuant to conversion of warrants
2 weeks agoAllotment of equity shares pursuant to conversion of warrants
2 weeks agoApproval of Q 1 financial results for FY 2026-27
2 weeks agoApproval of Q 1 financial results for FY 2026-27
2 weeks agoResgination of Independent Directors
2 weeks agoResgination of Independent Directors
2 weeks agoApproval of Q 1 financial results FY 2026-27 in alia considered other matters.
2 weeks agoApproval of Q 1 financial results FY 2026-27 in alia considered other matters.
2 weeks agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Shankar Varadharajan & PACs
3 weeks agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Shankar Varadharajan & PACs
3 weeks agoMonitoring Agency Report for quarter ended 30th June 2026
3 weeks agoMonitoring Agency Report for quarter ended 30th June 2026
3 weeks agoAllotment of equity shares pursuant to conversion of warrants
3 weeks agoAllotment of equity shares pursuant to conversion of warrants
3 weeks agoAllotment of Equity shares pursuant to Conversion of warrants.
3 weeks agoAllotment of Equity shares pursuant to Conversion of warrants.
3 weeks agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Shankar Varadharajan & PACs
3 weeks agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Shankar Varadharajan & PACs
3 weeks agoAllotment of 23 00 000 Equity shares pursuant to conversion of warrants
3 weeks agoAllotment of 23 00 000 Equity shares pursuant to conversion of warrants
3 weeks agoNewspaper Advt- Special Window for Re-lodgement of Transfer Request for Physical Shares
3 weeks agoNewspaper Advt- Special Window for Re-lodgement of Transfer Request for Physical Shares
3 weeks agoFischer Medical Ventures Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 inter alia to consider and approve un-audited financial results for quarter ended 30th June 2026
3 weeks agoFischer Medical Ventures Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 inter alia to consider and approve un-audited financial results for quarter ended 30th June 2026
3 weeks agoTime Medical International Ventures (India) Pvt Ltd a wholly owned subsidiary of Fischer Medical Ventures Limited announces partnership for Installation of Inter-Op MRI Suite.
1 month agoTime Medical International Ventures (India) Pvt Ltd a wholly owned subsidiary of Fischer Medical Ventures Limited announces partnership for Installation of Inter-Op MRI Suite.
1 month agoFischer Medical Ventures Secures CDSCO Import Approval for Spincare- Indias First Regulatory Clearance for a Portable Electrospun Wound Care System.
1 month agoFischer Medical Ventures Secures CDSCO Import Approval for Spincare- Indias First Regulatory Clearance for a Portable Electrospun Wound Care System.
1 month agoCertificate under Reg 74(5) of SEBI(DP) Regulations 2018 for quarter ended 30th June 2026
1 month agoCertificate under Reg 74(5) of SEBI(DP) Regulations 2018 for quarter ended 30th June 2026
1 month agoClosure of Trading Window for Q1 financial results
2 months agoClosure of Trading Window for Q1 financial results
2 months agoNewspaper Publication for Share Transfer related
2 months agoNewspaper Publication for Share Transfer related
2 months agoAnnual reports
Concalls & investor presentations
Nov 2025
ConcallPresentation
Corporate Actions
Date
Type
Details
2025-09-22
Dividend
0.005
2025-09-22
Dividend
0.05
2025-09-12
Split
10:1
Company details
Registered office
Survey No. 480/2 A P Medtech Zone Nadupura Village Pedagantyadu Mandal Vijayawada Andhra Pradesh PIN: 530032 Tel No: 08655550209 Fax No: NULL Email: [email protected] Internet: www.fischermv.com
Registrars
17-20 Jaferbhoy Industrial Estate , 1st Floor,Makwana Road,Marol Naka,Mumbai 17-20 Jaferbhoy Industrial Estate , 1st Floor Makwana Road Marol Naka PIN: Tel No: 022-42270400 Fax No: 022-28503748 Email: [email protected] Internet: www.adroitcorporate.com
Management
Ravindran Govindan, Chairman & Managing Director
Ravindran Govindan, Chairman & Managing Director
Svetlana Rao Raviwada, Whole Time Director
Khairy Jamaluddin Abu Bakar, Non Executive Independent Director
Roberto M Pagdanganan, Non Executive Independent Director
Sanjay Jayantilal Jain, Non Executive Independent Director
Jaya Ankur Singhania, Non Executive Independent Director
Balaji Gandla, Company Secretary & Compliance Officer
Details
BSE 524743
NSE FISCHER
ISIN INE771F01041